CC BY-NC-ND 4.0 · South Asian J Cancer 2024; 13(01): 063-065
DOI: 10.1055/s-0043-1774729
Viewpoint
COVID and cancer

Neuralink and Brain–Computer Interface—Exciting Times for Artificial Intelligence

Purvish Mahendra Parikh
1   Department of Clinical Hematology, Mahatma Gandhi University of Medical Sciences and Technology, Sitapur, Jaipur, Rajasthan, India
,
2   National Oncology Centre, The Royal Hospital, Muscat, Oman
› Author Affiliations

Abstract

Zoom Image
Purvish Mahendra Parikh

Brain–computer interfaces are becoming a tangible reality, capable of significantly aiding patients in real-world scenarios. The recent approval by the U.S. Food and Drug Administration for clinical human trials of Neuralink marks a monumental stride, comparable to Mr. Armstrong's moonwalk. Numerous other companies are also pioneering innovative solutions in this domain. Presently, over 150,000 patients in the United States possess brain implants. As technology advances, it holds the potential to alleviate various conditions, notably motor paralysis, cerebral palsy, and involuntary movements.



Publication History

Article published online:
15 April 2024

© 2024. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India